Cargando…
Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats
A low resting heart rate (HR) would be of great benefit in cardiovascular diseases. Ivabradine—a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide gated (HCN) channels- has emerged as a promising HR lowering drug. Its effects on the autonomic HR control are little known. Thi...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960883/ https://www.ncbi.nlm.nih.gov/pubmed/27507948 http://dx.doi.org/10.3389/fphys.2016.00305 |
_version_ | 1782444606567219200 |
---|---|
author | Silva, Fernanda C. Paiva, Franciny A. Müller-Ribeiro, Flávia C. Caldeira, Henrique M. A. Fontes, Marco A. P. de Menezes, Rodrigo C. A. Casali, Karina R. Fortes, Gláucia H. Tobaldini, Eleonora Solbiati, Monica Montano, Nicola Dias Da Silva, Valdo J. Chianca, Deoclécio A. |
author_facet | Silva, Fernanda C. Paiva, Franciny A. Müller-Ribeiro, Flávia C. Caldeira, Henrique M. A. Fontes, Marco A. P. de Menezes, Rodrigo C. A. Casali, Karina R. Fortes, Gláucia H. Tobaldini, Eleonora Solbiati, Monica Montano, Nicola Dias Da Silva, Valdo J. Chianca, Deoclécio A. |
author_sort | Silva, Fernanda C. |
collection | PubMed |
description | A low resting heart rate (HR) would be of great benefit in cardiovascular diseases. Ivabradine—a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide gated (HCN) channels- has emerged as a promising HR lowering drug. Its effects on the autonomic HR control are little known. This study assessed the effects of chronic treatment with ivabradine on the modulatory, reflex and tonic cardiovascular autonomic control and on the renal sympathetic nerve activity (RSNA). Male Wistar rats were divided in 2 groups, receiving intraperitoneal injections of vehicle (VEH) or ivabradine (IVA) during 7 or 8 consecutive days. Rats were submitted to vessels cannulation to perform arterial blood pressure (AP) and HR recordings in freely moving rats. Time series of resting pulse interval and systolic AP were used to measure cardiovascular variability parameters. We also assessed the baroreflex, chemoreflex and the Bezold-Jarish reflex sensitivities. To better evaluate the effects of ivabradine on the autonomic control of the heart, we performed sympathetic and vagal autonomic blockade. As expected, ivabradine-treated rats showed a lower resting (VEH: 362 ± 16 bpm vs. IVA: 260 ± 14 bpm, p = 0.0005) and intrinsic HR (VEH: 369 ± 9 bpm vs. IVA: 326 ± 11 bpm, p = 0.0146). However, the chronic treatment with ivabradine did not change normalized HR spectral parameters LF (nu) (VEH: 24.2 ± 4.6 vs. IVA: 29.8 ± 6.4; p > 0.05); HF (nu) (VEH: 75.1 ± 3.7 vs. IVA: 69.2 ± 5.8; p > 0.05), any cardiovascular reflexes, neither the tonic autonomic control of the HR (tonic sympathovagal index; VEH: 0.91± 0.02 vs. IVA: 0.88 ± 0.03, p = 0.3494). We performed the AP, HR and RSNA recordings in urethane-anesthetized rats. The chronic treatment with ivabradine reduced the resting HR (VEH: 364 ± 12 bpm vs. IVA: 207 ± 11 bpm, p < 0.0001), without affecting RSNA (VEH: 117 ± 16 vs. IVA: 120 ± 9 spikes/s, p = 0.9100) and mean arterial pressure (VEH: 70 ± 4 vs. IVA: 77 ± 6 mmHg, p = 0.3293). Our results suggest that, in health rats, the long-term treatment with ivabradine directly reduces the HR without changing the RSNA modulation and the reflex and tonic autonomic control of the heart. |
format | Online Article Text |
id | pubmed-4960883 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49608832016-08-09 Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats Silva, Fernanda C. Paiva, Franciny A. Müller-Ribeiro, Flávia C. Caldeira, Henrique M. A. Fontes, Marco A. P. de Menezes, Rodrigo C. A. Casali, Karina R. Fortes, Gláucia H. Tobaldini, Eleonora Solbiati, Monica Montano, Nicola Dias Da Silva, Valdo J. Chianca, Deoclécio A. Front Physiol Physiology A low resting heart rate (HR) would be of great benefit in cardiovascular diseases. Ivabradine—a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide gated (HCN) channels- has emerged as a promising HR lowering drug. Its effects on the autonomic HR control are little known. This study assessed the effects of chronic treatment with ivabradine on the modulatory, reflex and tonic cardiovascular autonomic control and on the renal sympathetic nerve activity (RSNA). Male Wistar rats were divided in 2 groups, receiving intraperitoneal injections of vehicle (VEH) or ivabradine (IVA) during 7 or 8 consecutive days. Rats were submitted to vessels cannulation to perform arterial blood pressure (AP) and HR recordings in freely moving rats. Time series of resting pulse interval and systolic AP were used to measure cardiovascular variability parameters. We also assessed the baroreflex, chemoreflex and the Bezold-Jarish reflex sensitivities. To better evaluate the effects of ivabradine on the autonomic control of the heart, we performed sympathetic and vagal autonomic blockade. As expected, ivabradine-treated rats showed a lower resting (VEH: 362 ± 16 bpm vs. IVA: 260 ± 14 bpm, p = 0.0005) and intrinsic HR (VEH: 369 ± 9 bpm vs. IVA: 326 ± 11 bpm, p = 0.0146). However, the chronic treatment with ivabradine did not change normalized HR spectral parameters LF (nu) (VEH: 24.2 ± 4.6 vs. IVA: 29.8 ± 6.4; p > 0.05); HF (nu) (VEH: 75.1 ± 3.7 vs. IVA: 69.2 ± 5.8; p > 0.05), any cardiovascular reflexes, neither the tonic autonomic control of the HR (tonic sympathovagal index; VEH: 0.91± 0.02 vs. IVA: 0.88 ± 0.03, p = 0.3494). We performed the AP, HR and RSNA recordings in urethane-anesthetized rats. The chronic treatment with ivabradine reduced the resting HR (VEH: 364 ± 12 bpm vs. IVA: 207 ± 11 bpm, p < 0.0001), without affecting RSNA (VEH: 117 ± 16 vs. IVA: 120 ± 9 spikes/s, p = 0.9100) and mean arterial pressure (VEH: 70 ± 4 vs. IVA: 77 ± 6 mmHg, p = 0.3293). Our results suggest that, in health rats, the long-term treatment with ivabradine directly reduces the HR without changing the RSNA modulation and the reflex and tonic autonomic control of the heart. Frontiers Media S.A. 2016-07-26 /pmc/articles/PMC4960883/ /pubmed/27507948 http://dx.doi.org/10.3389/fphys.2016.00305 Text en Copyright © 2016 Silva, Paiva, Müller-Ribeiro, Caldeira, Fontes, de Menezes, Casali, Fortes, Tobaldini, Solbiati, Montano, Dias Da Silva and Chianca. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Silva, Fernanda C. Paiva, Franciny A. Müller-Ribeiro, Flávia C. Caldeira, Henrique M. A. Fontes, Marco A. P. de Menezes, Rodrigo C. A. Casali, Karina R. Fortes, Gláucia H. Tobaldini, Eleonora Solbiati, Monica Montano, Nicola Dias Da Silva, Valdo J. Chianca, Deoclécio A. Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats |
title | Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats |
title_full | Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats |
title_fullStr | Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats |
title_full_unstemmed | Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats |
title_short | Chronic Treatment with Ivabradine Does Not Affect Cardiovascular Autonomic Control in Rats |
title_sort | chronic treatment with ivabradine does not affect cardiovascular autonomic control in rats |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960883/ https://www.ncbi.nlm.nih.gov/pubmed/27507948 http://dx.doi.org/10.3389/fphys.2016.00305 |
work_keys_str_mv | AT silvafernandac chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT paivafrancinya chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT mullerribeiroflaviac chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT caldeirahenriquema chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT fontesmarcoap chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT demenezesrodrigoca chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT casalikarinar chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT fortesglauciah chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT tobaldinieleonora chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT solbiatimonica chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT montanonicola chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT diasdasilvavaldoj chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats AT chiancadeoclecioa chronictreatmentwithivabradinedoesnotaffectcardiovascularautonomiccontrolinrats |